Quiz - Monitoring Glycemic Control - CommPharm Consulting

This quiz tests on some of the key issues from Chapter 9 – Monitoring Glycemic Control from the Diabetes Canada Guidelines. Hopefully this helps you prepare for the CDE exam.

Questions

1. What percentage of the A1C value does the mean blood glucose level in the last 30 days contribute to the result>

10%

25%

50%

75%

Question 1 of 11

2. In which of the following situations should a clinician consider assessing A1C level every 6 months?

Never, clinicians should always assess A1C every 3 months

In patients only managed with oral antihyperglycemic agents

In patients with type 2 diabetes

In patients where glycemic targets are consistently achieved

Question 2 of 11

3. Which of the following statements regarding point of care A1C is TRUE?

It is not recommended for assessing A1C

It is approved for the diagnosis of diabetes

It improves access to underserved populations

It should never be used to adjust the patient’s diabetes regimen

Question 3 of 11

4. Which of the following has been shown to decrease A1C levels?

Iron deficiency

Alcoholism

Decreased erythropoiesis

Rheumatoid arthritis

Question 4 of 11

5. TD is currently using insulin glargine 30 units HS and insulin aspart 6 units prior to her meals. What is the recommended minimum SMBG testing frequency?

Once per day

Twice per day

Three times per day

Four times per day

Question 5 of 11

6. Which of the following patient populations should test at least once per day according to the Diabetes Canada guidelines?

Patient taking basal insulin at bedtime and bolus insulin prior to supper

Patient starting prednisone

Newly diagnosed with diabetes (<6 months)

Patient treated with healthy behaviour interventions

Question 6 of 11

7. KL is started on basal insulin at bedtime. What is the optimal time per day to use SMBG to titrate the basal insulin to target?

Before breakfast

2 hours after breakfast

Before supper

Before bedtime

Question 7 of 11

8. LK wants to discuss alternate site testing with SMBG. Which of the following statements is TRUE?

Alternate site testing only occurs on the forearm and palm

Alternate site testing is as accurate at reflecting glycemic status as fingertip testing

Alternate site testing is most accurate after meals

The BG values of the palm near the base of the thumb closely correlates to fingertip BG

Question 8 of 11

9. Which of the following statements regarding ketone testing is TRUE?

DKA is recommended for patients with type 1 diabetes who are ill with a BG > 11 mmol/L

A patient with type 1 diabetes who is ill and is experiencing nausea, vomiting or abdominal pain should test ketones

Ketone testing is not recommended in type 2 diabetes

Blood ketone testing measures acetoacetate where blood ketone testing measures beta-hydroxybutyric acid (beta-OHB)

Question 9 of 11

10. Patient PY is in to see her diabetes educator. She asks about continuous glucose monitoring (CGM). Which of the following statements is TRUE?

CGM provides information directly to the user by displaying moment-to–moment absolute glucose levels and trending arrows

CGM is a replacement for SMBG

CGM has been shown to decrease A1C in adults with type 1 diabetes but not type 2 diabetes

CGM is not recommended in pregnancy

Question 10 of 11

11. Which of the following regarding flash glucose monitoring (FGM) is TRUE?

FGM measures capillary blood glucose levels

FGM must be calibrated by SMBG

FGM can store up to 24 hours of results

The sensor can be worn continuously for up to 14 days.

Question 11 of 11

Links to Other CDE Exam Prep Tools

Diabetes CDE Tools

Like this:

Like Loading...

Blog

Quiz – Monitoring Glycemic Control

Questions

Links to Other CDE Exam Prep Tools

Like this:

Questions

Links to Other CDE Exam Prep Tools

Share this:

Like this: